Overview

A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers

Status:
Completed

Trial end date:
2018-05-06

Target enrollment:

Participant gender:

Summary

The main objective of this study was to compare the bioavailability of two test formulations of Naloxone Nasal Spray with the reference formulations of Naloxone HCl IV and IM injection under fasted conditions.

Phase:

Phase 1

Details

Lead Sponsor:

INSYS Therapeutics Inc

Treatments:

Naloxone